Currently holds a position at Beyond Air Inc
Position | Company | Period |
---|---|---|
Independent Director | Beyond Air Inc | Aug. 13, 2018 - |
President - Medical, Research and Development and Chief Development Officer | Salix Pharmaceuticals Ltd | Feb. 2, 2015 - April 1, 2015 |
Executive Vice President - Research and Development, Chief Medical Officer, Chief Development Officer | Salix Pharmaceuticals Ltd | Jan. 1, 2010 - Feb. 2, 2015 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-11-21 | 2023-11-17 |
Heron Therapeutics Inc
(HRTX)
|
B Purchase |
25,000
+46.3%
1.0927,250 USD |
25,000 +46.3% | 1.09 | 27,250 USD | |
2023-11-20 | 2023-11-16 |
Heron Therapeutics Inc
(HRTX)
|
B Purchase |
50,000
+1250.0%
0.9446,995 USD |
50,000 +1250.0% | 0.94 | 46,995 USD | |
2023-04-03 | 2023-03-31 |
Beyond Air Inc
(XAIR)
|
B Purchase |
5,000
+50.7%
6.6733,350 USD |
5,000 +50.7% | 6.67 | 33,350 USD | |
2023-03-20 | 2023-03-17 |
Beyond Air Inc
(XAIR)
|
B Purchase |
5,000
+103.0%
6.4632,300 USD |
5,000 +103.0% | 6.46 | 32,300 USD |